Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1866-1876

  Luo, Deyan ^a   Szaba, Frank M ^a   Kummer, Lawrence W ^a   Plow, Edward F ^b   Mackman, Nigel ^c   Gailani, David ^d   Smiley, Stephen T ^a  

^a TRUDEAU INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; CHEMOKINE; CYTOKINE; FIBRIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; BLOOD CLOTTING; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBRIN DEPOSITION; HOST RESISTANCE; INFECTION RESISTANCE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE; YERSINIA ENTEROCOLITICA; YERSINIOSIS;

ANIMALS; CARBOXYPEPTIDASE U; FACTOR XI; FIBRIN; HUMANS; LIVER; MICE; MICE, KNOCKOUT; SEPSIS; SERPIN E2; THROMBOPLASTIN; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 80051919546     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101094     Document Type: Article

References (59)

1. Levi, M. 2007. Disseminated intravascular coagulation. Crit. Care Med. 35: 2191-2195. (Pubitemid 47326459)
2. Levi, M., and T. Van der Poll. 2010. Inflammation and coagulation. Crit. Care Med. 38: S26-S34.
3. Johnson, L. L., K. N. Berggren, F. M. Szaba, W. Chen, and S. T. Smiley. 2003. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197: 801-806. (Pubitemid 36350874)
4. Mullarky, I. K., F. M. Szaba, K. N. Berggren, M. A. Parent, L. W. Kummer, W. Chen, L. L. Johnson, and S. T. Smiley. 2005. Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis. Infect. Immun. 73: 3888-3895. (Pubitemid 40923126)
5. Flick, M. J., X. Du, D. P. Witte, M. Jirousková, D. A. Soloviev, S. J. Busuttil, E. F. Plow, and J. L. Degen. 2004. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J. Clin. Invest. 113: 1596-1606. (Pubitemid 39071683)
6. Ahrenholz, D. H., and R. L. Simmons. 1980. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery 88: 41-47. (Pubitemid 10086992)
7. Echtenacher, B., K. Weigl, N. Lehn, and D. N. Männel. 2001. Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect. Immun. 69: 3550-3555. (Pubitemid 32493266)
8. Wright, S. D., J. I. Weitz, A. J. Huang, S. M. Levin, S. C. Silverstein, and J. D. Loike. 1988. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. USA 85: 7734-7738.
9. Loike, J. D., B. Sodeik, L. Cao, S. Leucona, J. I. Weitz, P. A. Detmers, S. D. Wright, and S. C. Silverstein. 1991. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A a chain of fibrinogen. Proc. Natl. Acad. Sci. USA 88: 1044-1048. (Pubitemid 21916161)
10. Szaba, F. M., and S. T. Smiley. 2002. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99: 1053-1059. (Pubitemid 34525570)
11. Adams, R. A., C. Schachtrup, D. Davalos, I. Tsigelny, and K. Akassoglou. 2007. Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: Lessons from multiple sclerosis. Curr. Med. Chem. 14: 2925-2936. (Pubitemid 350201659)
12. Tapper, H., and H. Herwald. 2000. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 96: 2329-2337.
13. Bergmann, S., and S. Hammerschmidt. 2007. Fibrinolysis and host response in bacterial infections. Thromb. Haemost. 98: 512-520. (Pubitemid 47412877)
14. Tilley, R., and N. Mackman. 2006. Tissue factor in hemostasis and thrombosis. Semin. Thromb. Hemost. 32: 5-10.
15. Oehmcke, S., and H. Herwald. 2010. Contact system activation in severe infectious diseases. J. Mol. Med. 88: 121-126.
16. Esmon, C. T. 2006. Inflammation and the activated protein C anticoagulant pathway. Semin. Thromb. Hemost. 32(Suppl. 1): 49-60.
17. Lijnen, H. R. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. J. Thromb. Haemost. 3: 35-45. (Pubitemid 41647113)
18. Hermans, P. W., and J. A. Hazelzet. 2005. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis. Clin. Infect. Dis. 41(Suppl. 7): S453-S458. (Pubitemid 41598305)
19. Bajzar, L. 2000. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway. Arterioscler. Thromb. Vasc. Biol. 20: 2511-2518.
20. Morser, J., E. C. Gabazza, T. Myles, and L. L. Leung. 2010. What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse? J. Thromb. Haemost. 8: 868-876.
21. Taylor, F. B., Jr., A. Chang, W. Ruf, J. H. Morrissey, L. Hinshaw, R. Catlett, K. Blick, and T. S. Edgington. 1991. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ. Shock 33: 127-134.
22. Pawlinski, R., B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, W. Boisvert, P. Andrade-Gordon, R. D. Frank, and N. Mackman. 2004. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 103: 1342-1347. (Pubitemid 38168646)
23. Bernard, G. R., J. L. Vincent, P. F. Laterre, S. P. LaRosa, J. F. Dhainaut, A. Lopez-Rodriguez, J. S. Steingrub, G. E. Garber, J. D. Helterbrand, E. W. Ely, C. J. Fisher Jr.; Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344: 699-709. (Pubitemid 32204987)
24. Levi, M. 2008. Activated protein C in sepsis: A critical review. Curr. Opin. Hematol. 15: 481-486.
25. Tucker, E. I., D. Gailani, S. Hurst, Q. Cheng, S. R. Hanson, and A. Gruber. 2008. Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis. J. Infect. Dis. 198: 271-274. (Pubitemid 352019293)
26. Binette, T. M., F. B. Taylor, Jr., G. Peer, and L. Bajzar. 2007. Thrombin-thrombomodulin connects coagulation and fibrinolysis: More than an in vitro phenomenon. Blood 110: 3168-3175. (Pubitemid 350106308)
27. Develter, J., N. A. Booth, P. J. Declerck, and A. Gils. 2008. Bispecific targeting of thrombin activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 by a heterodimer diabody. J. Thromb. Haemost. 6: 1884-1891.
28. Kinasewitz, G. T., S. B. Yan, B. Basson, P. Comp, J. A. Russell, A. Cariou, S. L. Um, B. Utterback, P. F. Laterre, J. F. Dhainaut; PROWESS Sepsis Study Group. 2004. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit. Care 8: R82-R90.
29. Buras, J. A., B. Holzmann, and M. Sitkovsky. 2005. Animal models of sepsis: Setting the stage. Nat. Rev. Drug Discov. 4: 854-865. (Pubitemid 41553966)
30. Dyson, A., and M. Singer. 2009. Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting? Crit. Care Med. 37: S30-S37.
31. Dejager, L., I. Pinheiro, E. Dejonckheere, and C. Libert. 2011. Cecal ligation and puncture: The gold standard model for polymicrobial sepsis? Trends Microbiol. 19: 198-208.
32. Carter, P. B. 1975. Pathogenecity of Yersinia enterocolitica for mice. Infect. Immun. 11: 164-170.
33. Heesemann, J., K. Gaede, and I. B. Autenrieth. 1993. Experimental Yersinia enterocolitica infection in rodents: A model for human yersiniosis. APMIS 101: 417-429. (Pubitemid 23255821)
34. Cover, T. L., and R. C. Aber. 1989. Yersinia enterocolitica. N. Engl. J. Med. 321: 16-24. (Pubitemid 19170380)
35. Bouza, E., A. Dominguez, M. Meseguer, L. Buzon, D. Boixeda, M. J. Revillo, L. De Rafael, and J. Martinez-Beltran. 1980. Yersinia enterocolitica septicemia. Am. J. Clin. Pathol. 74: 404-409. (Pubitemid 10021464)
36. Tipple, M. A., L. A. Bland, J. J. Murphy, M. J. Arduino, A. L. Panlilio, J. J. Farmer, III, M. A. Tourault, C. R. Macpherson, J. E. Menitove, A. J. Grindon, et al. 1990. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion 30: 207-213. (Pubitemid 20112721)
37. Strobel, E., J. Heesemann, G. Mayer, J. Peters, S. Müller-Weihrich, and P. Emmerling. 2000. Bacteriological and serological findings in a further case of transfusion-mediated Yersinia enterocolitica sepsis. J. Clin. Microbiol. 38: 2788-2790. (Pubitemid 30485176)
38. Hoelen, D. W., D. H. Tjan, M. A. Schouten, B. C. Dujardin, and A. R. Van Zanten. 2007. Severe Yersinia enterocolitica sepsis after blood transfusion. Neth. J. Med. 65: 301-303. (Pubitemid 47520933)
39. Suh, T. T., K. Holmbäck, N. J. Jensen, C. C. Daugherty, K. Small, D. I. Simon, S. Potter, and J. L. Degen. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9: 2020-2033.
40. Gailani, D., N. M. Lasky, and G. J. Broze Jr. 1997. A murine model of factor XI deficiency. Blood Coagul. Fibrinolysis 8: 134-144. (Pubitemid 27211727)
41. Swaisgood, C. M., D. Schmitt, D. Eaton, and E. F. Plow. 2002. In vivo regulation of plasminogen function by plasma carboxypeptidase B. J. Clin. Invest. 110: 1275-1282. (Pubitemid 35291121)
42. Parry, G. C., J. H. Erlich, P. Carmeliet, T. Luther, and N. Mackman. 1998. Low levels of tissue factor are compatible with development and hemostasis in mice. J. Clin. Invest. 101: 560-569. (Pubitemid 28084238)
43. Mullarky, I. K., F. M. Szaba, C. G. Winchel, M. A. Parent, L. W. Kummer, N. Mackman, L. L. Johnson, and S. T. Smiley. 2006. In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis. J. Thromb. Haemost. 4: 1580-1587.
44. Massberg, S., L. Grahl, M. L. Von Bruehl, D. Manukyan, S. Pfeiler, C. Goosmann, V. Brinkmann, M. Lorenz, K. Bidzhekov, A. B. Khandagale, et al. 2010. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16: 887-896.
45. Delvaeye, M., and E. M. Conway. 2009. Coagulation and innate immune responses: Can we view them separately? Blood 114: 2367-2374.
46. Rebeil, R., R. K. Ernst, B. B. Gowen, S. I. Miller, and B. J. Hinnebusch. 2004. Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 52: 1363-1373. (Pubitemid 38746310)
47. Van Schaik, S. M., and A. K. Abbas. 2007. Role of T cells in a murine model of Escherichia coli sepsis. Eur. J. Immunol. 37: 3101-3110.
48. Silva, A. T., and J. Cohen. 1992. Role of interferon-gamma in experimental Gram-negative sepsis. J. Infect. Dis. 166: 331-335.
49. Campbell, W. D., E. Lazoura, N. Okada, and H. Okada. 2002. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46: 131-134. (Pubitemid 34194973)
50. Renckens, R., J. J. Roelofs, S. A. ter Horst, C. Van 't Veer, S. R. Havik, S. Florquin, G. T. Wagenaar, J. C. Meijers, and T. Van der Poll. 2005. Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice. J. Immunol. 175: 6764-6771. (Pubitemid 41598921)
51. Renckens, R., J. J. Roelofs, P. I. Bonta, S. Florquin, C. J. De Vries, M. Levi, P. Carmeliet, C. Van't Veer, and T. Van der Poll. 2007. Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 109: 1593-1601. (Pubitemid 46239593)
52. Mutch, N. J., L. Thomas, N. R. Moore, K. M. Lisiak, and N. A. Booth. 2007. TAFIa, PAI-1 and alpha-antiplasmin: Complementary roles in regulating lysis of thrombi and plasma clots. J. Thromb. Haemost. 5: 812-817. (Pubitemid 46563582)
53. Takahashi, K., W. C. Chang, M. Takahashi, V. Pavlov, Y. Ishida, L. La Bonte, L. Shi, T. Fujita, G. L. Stahl, and E. M. Van Cott. 2011. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 216: 96-102.
54. Fan, S. T., and T. S. Edgington. 1993. Integrin regulation of leukocyte inflammatory functions: CD11b/CD18 enhancement of the tumor necrosis factor-αresponses of monocytes. J. Immunol. 150: 2972-2980.
55. Perez, R. L., and J. Roman. 1995. Fibrin enhances the expression of IL-1β by human peripheral blood mononuclear cells: Implications in pulmonary inflammation. J. Immunol. 154: 1879-1887.
56. Smiley, S. T., J. A. King, and W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167: 2887-2894. (Pubitemid 32768923)
57. Stouthard, J. M., M. Levi, C. E. Hack, C. H. Veenhof, H. A. Romijn, H. P. Sauerwein, and T. Van der Poll. 1996. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb. Haemost. 76: 738-742. (Pubitemid 26388179)
58. Dube, P. H., S. A. Handley, J. Lewis, and V. L. Miller. 2004. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect. Immun. 72: 3561-3570. (Pubitemid 38697784)
59. Levi, M., and T. Van der Poll. 2004. Coagulation in sepsis: All bugs bite equally. Crit. Care 8: 99-100. (Pubitemid 38436414)